European Medicines Agency (EMA) virtual press briefing -HPV Safety Review 2015

Jun 23, 2017 | Video

European Medicines Agency (EMA) virtual press briefing – Human papillomavirus (HPV) vaccines

Recommendation from the Pharmacovigilance Risk Assessment Committee (PRAC), 5th November 2015

Comparing reported Adverse Reactions to vaccines in UK

Independent-graph

Follow Us

Recent Tweets

RT @chrishendel: I'm still thinking about this very salient point raised by authors @MaryanneDemasi & Tom Jefferson in this important comme…
2 months ago • Reply • Retweet • Favorite
See comments, 2nd page, on the control arm of the clinical trials of the HPV vaccine. twitter.com/MaryanneDemasi…
2 months ago • Reply • Retweet • Favorite
RT @PGtzsche1: HPV vaccines increased serious nervous system disorders, risk ratio 1.49 (1.02 to 2.16, P = 0.04), even though active compar…
3 months ago • Reply • Retweet • Favorite
RT @K11235589: @caronryalls @DrAseemMalhotra @RebeccaChandle1 & post-marketing surveillance hopeless bec Yellow Card records individual sym…
5 months ago • Reply • Retweet • Favorite
RT @caronryalls: @DrAseemMalhotra Little accurate published data bec poor design of follow up studies - usually require a condition to be d…
5 months ago • Reply • Retweet • Favorite

Follow @TimeForActionUK

Pin It on Pinterest

Share This